These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33838295)

  • 41. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients.
    Abuzeineh M; Kyeso Y; Philogene MC; Alachkar N; Alasfar S
    Transplant Proc; 2021 Jun; 53(5):1501-1508. PubMed ID: 33573814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody.
    In JW; Park H; Rho EY; Shin S; Park KU; Park MH; Song EY
    Transplant Proc; 2014 Dec; 46(10):3371-4. PubMed ID: 25498054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH; Chen L; Zuckerman JE; Weng PL; Chambers ET; Zhang Q; Reed EF
    Transplantation; 2024 Jan; 108(1):276-283. PubMed ID: 37527494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Angiotensin II type I-receptor antibodies in transplant glomerulopathy.
    Bussolino S; Dolla C; Ariaudo C; Civiletti F; Messina M; Mella A; Caorsi C; Amoroso A; Barreca A; Papotti M; Giunti S; Fop F; Biancone L
    Clin Transplant; 2018 Nov; 32(11):e13407. PubMed ID: 30218593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation.
    Xu Q; McAlister VC; Leckie S; House AA; Skaro A; Marotta P
    Am J Transplant; 2020 Jan; 20(1):282-288. PubMed ID: 31419065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes.
    Redondo-Pachón D; Pérez-Sáez MJ; Mir M; Gimeno J; Llinás L; García C; Hernández JJ; Yélamos J; Pascual J; Crespo M
    Hum Immunol; 2018 Jun; 79(6):424-431. PubMed ID: 29524568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation.
    Sorohan BM; Sinescu I; Tacu D; Bucșa C; Țincu C; Obrișcă B; Berechet A; Constantinescu I; Mărunțelu I; Ismail G; Baston C
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
    Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
    Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
    Lee J; Park Y; Kim BS; Lee JG; Kim HJ; Kim YS; Huh KH
    Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.
    Delville M; Lamarthée B; Pagie S; See SB; Rabant M; Burger C; Gatault P; Giral M; Thaunat O; Arzouk N; Hertig A; Hazzan M; Matignon M; Mariat C; Caillard S; Kamar N; Sayegh J; Westeel PF; Garrouste C; Ladrière M; Vuiblet V; Rivalan J; Merville P; Bertrand D; Le Moine A; Duong Van Huyen JP; Cesbron A; Cagnard N; Alibeu O; Satchell SC; Legendre C; Zorn E; Taupin JL; Charreau B; Anglicheau D
    J Am Soc Nephrol; 2019 Apr; 30(4):692-709. PubMed ID: 30850439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation.
    Lee J; Huh KH; Park Y; Park BG; Yang J; Jeong JC; Lee J; Park JB; Cho JH; Lee S; Ro H; Han SY; Kim MS; Kim YS; Kim SJ; Kim CD; Chung W; Park SB; Ahn C;
    Nephrol Dial Transplant; 2017 Jul; 32(7):1244-1250. PubMed ID: 26546592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful Treatment of Anti-angiotensin II Type 1 Receptor Antibody-Associated Rejection in Kidney Transplantation: A Case Report.
    Wiwattanathum P; Ingsathit A; Thammanichanond D; Worawichawong S
    Transplant Proc; 2018 Apr; 50(3):877-880. PubMed ID: 29331505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J; López-Hoyos M; Rodrigo E; Gómez-Román J; Ruiz JC; Arias M; San Segundo D
    Transplant Proc; 2016 Nov; 48(9):2888-2890. PubMed ID: 27932099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin II type I receptor antibodies in pediatric solid organ transplant.
    Pearl MH; Reed EF
    Hum Immunol; 2019 Aug; 80(8):568-572. PubMed ID: 30926351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
    Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.
    Pearl MH; Chen L; ElChaki R; Elashoff D; Gjertson DW; Rossetti M; Weng PL; Zhang Q; Reed EF; Chambers ET
    Kidney Int Rep; 2020 Nov; 5(11):1925-1936. PubMed ID: 33163713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
    Abuzeineh M; Aala A; Alasfar S; Alachkar N
    BMC Nephrol; 2020 Jul; 21(1):253. PubMed ID: 32615995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.